These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8923290)

  • 21. Analysis of the cause of increased measles incidence in Xinjiang, China in 2004.
    Yu X; Wang S; Guan J; Mahemuti ; Purhati ; Gou A; Liu Q; Jin X; Ghildyal R
    Pediatr Infect Dis J; 2007 Jun; 26(6):513-8. PubMed ID: 17529869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ELISA underestimates measles antibody seroprevalence in US military recruits.
    Mancuso JD; Krauss MR; Audet S; Beeler JA
    Vaccine; 2008 Sep; 26(38):4877-8. PubMed ID: 18586062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A study on measles vaccination rate and its antibody level in children aged 12-24 months in Guangxi, 1989].
    Lin M
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Jun; 13(3):138-40. PubMed ID: 1423535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles virus haemagglutination-inhibition antibodies among pregnant and non-pregnant women in the vaccine era in Harare, Zimbabwe.
    Obi CL; Tswana SA; Moyo SR; Berejena C
    Cent Afr J Med; 1996 May; 42(5):135-8. PubMed ID: 8771931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humoral immunity in natural infection by tick-borne encephalitis virus.
    Venturi G; Martelli P; Mazzolini E; Fiorentini C; Benedetti E; Todone D; Villalta D; Fortuna C; Marchi A; Minelli G; Ciufolini MG
    J Med Virol; 2009 Apr; 81(4):665-71. PubMed ID: 19235849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
    Cohen BJ; Doblas D; Andrews N
    Vaccine; 2008 Nov; 26(50):6392-7. PubMed ID: 18834911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental measles. II. Infection and immunity in the rhesus macaque.
    Zhu YD; Heath J; Collins J; Greene T; Antipa L; Rota P; Bellini W; McChesney M
    Virology; 1997 Jun; 233(1):85-92. PubMed ID: 9229928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR; Schneider F; Muller CP
    Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoglobulin M antibody response to measles virus following natural virus infection, primary vaccination, and reexposure to the virus.
    Nates S; Rey G; Giordano M; Medeot S; Depetris A; Boshell J; de Wolff CD
    Viral Immunol; 1997; 10(3):165-73. PubMed ID: 9344339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measles virus-specific IgG4 antibody titer as a serologic marker of post-vaccinal immune response.
    Isa MB; Martínez LC; Ferreyra LJ; Giordano MO; Barril PA; Massachessi G; Nates SV
    Viral Immunol; 2006; 19(2):335-9. PubMed ID: 16817776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of measles antibody by hemagglutination inhibition assay in children in south-west and north-central Nigeria.
    Onoja AB; Adeniji AJ
    Int J Infect Dis; 2013 Jul; 17(7):e552-5. PubMed ID: 23510540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran.
    Karimi A; Arjomandi A; Alborzi A; Rasouli M; Kadivar MR; Obood B; Pourabbas B
    East Mediterr Health J; 2004; 10(4-5):468-73. PubMed ID: 16335636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The immunoassay of IgM antibodies in samples clinically suspected of measles].
    Ribas Antúnez MA; Arocha Rosete Y; Toraño Canto I; Rodríguez Valdés C
    Rev Cubana Med Trop; 1998; 50(2):105-9. PubMed ID: 10349427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
    Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T
    East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The rapid diagnosis of rubella and measles by the dot immunoassay method].
    Arroyave CM
    Bol Med Hosp Infant Mex; 1993 Jun; 50(6):399-405. PubMed ID: 8517935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination.
    Ueda K; Hashiguchi K; Nakashima F; Ueda S; Takahashi M
    Biken J; 1981 Sep; 24(3):119-22. PubMed ID: 7337678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sero-response to measles vaccination at 12 months of age in Saudi infants in Qassim Province.
    Khalil MK; Nadrah HM; Al-Yahia OA; Al-Saigul AM
    Saudi Med J; 2008 Jul; 29(7):1009-13. PubMed ID: 18626531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Passive hemagglutination test for measles immunity and serodiagnosis.
    Sakata H; Sugiura A
    J Clin Microbiol; 1988 Apr; 26(4):636-40. PubMed ID: 3130389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measles outbreak in Ibadan: clinical, serological and virological identification of affected children in selected hospitals.
    Adu FD; Ikusika A; Omotade O
    J Infect; 1997 Nov; 35(3):241-5. PubMed ID: 9459395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.